Search research articles
Contact Us
Filters
Showing results (1001-1010 of 2,446) with videos related to
Page
of 245
Sort By:
Brain Communications
|
September 4, 2024
Mapping functional traces of opioid memories in the rat brain
Joana Gomes-Ribeiro, João Martins, José Sereno, et al.
Brain Communications
|
August 26, 2024
Gene expression and brain imaging association study reveals gene signatures in major depressive disorder
Wei Liu, Jian-Po Su, Ling-Li Zeng, et al.
Brain Communications
|
August 30, 2024
Dissociable effects of mild COVID-19 on short- and long-term memories
Lauren Z Atkinson, Jude L Thom, Anna Christina Nobre, et al.
Brain Communications
|
August 21, 2024
Integrative approach of omics and imaging data to discover new insights for understanding brain diseases
Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, et al.
Brain Communications
|
August 22, 2024
Neural signatures of default mode network subsystems in first-episode, drug-naive patients with major depressive disorder after 6-week thought induction psychotherapy treatment
Fengmei Lu, Jinhua Zhang, Yihua Zhong, et al.
Brain Communications
|
November 20, 2024
Olfactory stimulation with multiple odorants prevents stress-induced cognitive and psychological alterations
Bruno Bandiera, Francesca Natale, Marco Rinaudo, et al.
Brain Communications
|
November 4, 2024
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Robin Ziyue Zhou, Frida Duell, Michael Axenhus, et al.
Brain Communications
|
August 12, 2024
<i>Drosophila</i> appear resistant to trans-synaptic tau propagation
James H Catterson, Edmond N Mouofo, Inés López De Toledo Soler, et al.
Brain Communications
|
August 12, 2024
Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study
Charly H A Billaud, Amanda G Wood, Daniel Griffiths-King, et al.
Brain Communications
|
August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Jorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Page
of 245
Search research articles
Search
Showing results (1001-1010 of 2,446) with videos related to
Sort By:
Page
of 245
Brain Communications
|
September 4, 2024
Mapping functional traces of opioid memories in the rat brain
Joana Gomes-Ribeiro, João Martins, José Sereno, et al.
Brain Communications
|
August 26, 2024
Gene expression and brain imaging association study reveals gene signatures in major depressive disorder
Wei Liu, Jian-Po Su, Ling-Li Zeng, et al.
Brain Communications
|
August 30, 2024
Dissociable effects of mild COVID-19 on short- and long-term memories
Lauren Z Atkinson, Jude L Thom, Anna Christina Nobre, et al.
Brain Communications
|
August 21, 2024
Integrative approach of omics and imaging data to discover new insights for understanding brain diseases
Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, et al.
Brain Communications
|
August 22, 2024
Neural signatures of default mode network subsystems in first-episode, drug-naive patients with major depressive disorder after 6-week thought induction psychotherapy treatment
Fengmei Lu, Jinhua Zhang, Yihua Zhong, et al.
Brain Communications
|
November 20, 2024
Olfactory stimulation with multiple odorants prevents stress-induced cognitive and psychological alterations
Bruno Bandiera, Francesca Natale, Marco Rinaudo, et al.
Brain Communications
|
November 4, 2024
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Robin Ziyue Zhou, Frida Duell, Michael Axenhus, et al.
Brain Communications
|
August 12, 2024
<i>Drosophila</i> appear resistant to trans-synaptic tau propagation
James H Catterson, Edmond N Mouofo, Inés López De Toledo Soler, et al.
Brain Communications
|
August 12, 2024
Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study
Charly H A Billaud, Amanda G Wood, Daniel Griffiths-King, et al.
Brain Communications
|
August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Jorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Page
of 245